Reviews in Basic and Clinical Gastroenterology and HepatologyHereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Section snippets
What Is Hemochromatosis?
The term “hemochromatosis” was coined by the German pathologist Friedrich Daniel Von Recklinghausen in a short report published in 188927 describing the bronze stain of organs that was attributed to blood-borne pigments. The term, he maintained, could be applied to different conditions, including “cases of pigmentary cirrhosis, whose association with diabetes,” he noted, “has led the French authors to ask whether the bronze pigment is ([as suggested by] Hanot and Schuchmann) over-produced in
What Causes Hemochromatosis?
Research in the 1930s showed that iron enters the human body exclusively through the small intestine (Table 1);4 once it enters, it has to be used or stored because there are no active physiological means for its removal apart from menstrual blood loss. In the 1950s and 1960s, metabolic studies of patients with hemochromatosis (most, if not all, of whom probably had HFE disease) revealed rates of dietary iron absorption by small intestinal enterocytes that exceeded iron loss by approximately 3
Defects in Iron Metabolism
Iron is an important dietary nutrient that is continuously recycled by the body; its uptake, storage, and utilization must be carefully coordinated at the cellular and systemic levels. Intracellular iron levels are controlled by iron regulatory proteins 1 and 2 (reviewed by Muckenthaler et al40), which are not significantly disrupted in patients with hemochromatosis. Less is known about the highly complex regulation of systemic iron traffic. Signals from storage compartments (mainly hepatocytes
The Common Pathogenic Basis for All Forms of Hemochromatosis
If one or more components of the blood iron-sensing machinery fail, adequate levels of hepcidin will not be produced in response to the increased levels of iron, intestinal and macrophage iron release will not be checked, and iron overload and hemochromatosis will result. In mice, loss of Hjv,80, 81Bmp6,32, 33Hfe,66TfR2,82Smad4,31neogenin,34C/EBP alpha,30 and Hamp itself83 all lead to reduced hepcidin synthesis and systemic iron overload that resembles hemochromatosis. In humans, hepcidin
How Frequently Do Cases of Hemochromatosis Occur?
The C282Y polymorphism in HFE is 10-fold more prevalent than the mutation that causes most cases of cystic fibrosis. HFE-related hemochromatosis would be the most frequently inherited metabolic disorder among white individuals if not for the fact that the phenotype penetrance of the polymorphism is low; C282Y increases the risk of hemochromatosis. Because of its prevalence in certain populations, C282Y is a polymorphic variant rather than a pathogenic mutation. Its mean allelic frequency based
Signs of Hemochromatosis
The clinical presentation of HFE-related hemochromatosis, which usually occurs in middle-aged patients, ranges from simple biochemical abnormalities to severe organ damage and disease.65 The variations in symptoms occur because C282Y HFE homozygosity only predisposes an individual to hemochromatosis; additional host or environmental factors are required. The classic presentation of hemochromatosis—unexplained cirrhosis, bronze-colored skin, diabetes (and other endocrine diseases), joint
How Is Hemochromatosis Managed?
Bloodletting (phlebotomy) is the standard treatment for all forms of hemochromatosis. It was first used in 1950 to eliminate excess iron in patients with hemochromatosis11 (Table 1). There are no evidence-based guidelines on the use of therapeutic phlebotomy. Systematic studies have never been conducted to determine when it should be started, how frequently it should be performed, or therapeutic end points. Treatment is conventionally initiated when serum ferritin levels exceed the normal
Perspectives
Hemochromatosis was originally considered to be an odd finding in autopsies that was probably alcohol related. More than a century later, hemochromatosis is recognized as a hereditary disorder associated with one of the most common polymorphisms among white people. We have made major advances in understanding this disease, but there is still much that we do not know, such as the exact role of HFE in iron metabolism. Hemochromatosis models of pathogenesis have been developed based on studies of
References (137)
Chlorosis: the rise and disappearance of a nutritional disease
J Nutr
(1995)- et al.
A novel mammalian iron-regulated protein involved in intracellular iron metabolism
J Biol Chem
(2000) - et al.
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation
Mol Cell
(2000) - et al.
Molecular cloning of transferrin receptor 2A new member of the transferrin receptor-like family
J Biol Chem
(1999) - et al.
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
FEBS Lett
(2000) - et al.
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload
J Biol Chem
(2001) - et al.
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
J Biol Chem
(2001) - et al.
Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features
Blood Cells Mol Dis
(2005) - et al.
Iron overload in the Asian community
Blood
(2009) - et al.
C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolismCross-talk between C/EBP pathway and iron metabolism
J Biol Chem
(2002)
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Cell Metab
Neogenin inhibits HJV secretion and regulates BMP induced hepcidin expression and iron homeostasis
Blood
ErythrokineticsIV. The plasma iron turnover as a measure of erythropoiesis
Blood
Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation
Blood
Mitochondrial dysfunction in cardiac disease: ischemia–reperfusion, aging, and heart failure
J Mol Cell Cardiol
Regulators of iron balance in humans
Blood
The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study
Blood
Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha
Blood
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
Blood
The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin
Cell Metab
The RGM/DRAGON family of BMP co-receptors
Cytokine Growth Factor Rev
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
Blood
Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells
J Biol Chem
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
Blood
Neogenin-mediated hemojuvelin shedding occurs after hemojuvelin traffics to the plasma membrane
J Biol Chem
Decreased liver hepcidin expression in the Hfe knockout mouse
Blood Cells Mol Dis
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
Lancet
Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron
Blood
Hfe acts in hepatocytes to prevent hemochromatosis
Cell Metab
Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing
J Biol Chem
The transferrin receptor modulates hfe-dependent regulation of hepcidin expression
Cell Metab
SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression
Blood
Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver
Blood
Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis
Gastroenterology
BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression
Blood
Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis
Blood
Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice
Blood
Hepcidin is decreased in TFR2 hemochromatosis
Blood
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes
Gastroenterology
A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation
Gastroenterology
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis
Clin Gastroenterol Hepatol
The ferroportin disease
Blood Cells Mol Dis
Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis
Gastroenterology
Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study
Mayo Clin Proc
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Nat Genet
Iron and heme: crucial carriers and catalysts
Sur la cristallisation de la ferritine
Soc Chim Biol
The absorption and excretion of iron before, during and after a period of very high intake
Biochem J
Glycosurie; diabete sucre
Clinique Med de l'Hotel de Paris
Diabète sucré
Bull Soc Anatomique Paris
Cited by (451)
Therapeutic potential and mechanisms of Rifaximin in ameliorating iron overload-induced ferroptosis and liver fibrosis in vivo and in vitro
2024, Toxicology and Applied PharmacologyMaternal and prenatal outcomes of hemochromatosis in pregnancy: A population-based study
2023, Clinics and Research in Hepatology and GastroenterologyH<inf>2</inf>S regulation of iron homeostasis by IRP1 improves vascular smooth muscle cell functions
2023, Cellular SignallingClinical and biochemical understanding of Zinc interaction during liver diseases: A paradigm shift
2023, Journal of Trace Elements in Medicine and Biology
Conflicts of interest The author discloses no conflicts.
Funding Supported by the PRIN 2008 grant from the Italian National Research Council.